Brief: Adverum Biotechnologies Announces Upcoming Nonclinical Data Presentation Supporting Its Gene Therapy
17/04/2023 23:09
April 17 (Reuters) - Adverum Biotechnologies Inc
ADVM.O :
* ADVERUM BIOTECHNOLOGIES ANNOUNCES UPCOMING NONCLINICAL
DATA
PRESENTATION SUPPORTING STAGGERED BILATERAL ADMINISTRATION OF
IXOBEROGENE SOROPARVOVEC (IXO-VEC) AT THE 2023 ARVO ANNUAL
MEETING
Source text for Eikon: ID:nGNX4kpncg
Further company coverage: ADVM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)